HOME › DRUGS › GLECAPREVIR;PIBRENTASVIR
ACTIVE SUBSTANCE / INN

GLECAPREVIR;PIBRENTASVIR

Brand name(s): Maviret
EMA LISTED
AUTHORISED
Hepatitis C, Chronic
ACTIVE SUBSTANCE
Glecaprevir;Pibrentasvir
REGULATORS
EMA
SPONSORS / MAH
AbbVie Deutschland GmbH & Co. KG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MaviretAbbVie Deutschland GmbH & Co. KGAuthorised26/07/2017Hepatitis C, Chronic

FULL INTELLIGENCE ON GLECAPREVIR;PIBRENTASVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →